You are here

Article info

Article menu
Basic tumor immunology
Original research
IFNγ mediates the resistance of tumor cells to distinct NK cell subsets

Authors

  • Tomáš Hofman Department of Immunobiochemistry, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Siu Wang Ng Signalling and Functional Genomics, German Cancer Research Centre, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Irene Garcés-Lázaro Department of Immunobiochemistry, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Florian Heigwer Signalling and Functional Genomics, German Cancer Research Centre, Heidelberg, GermanyDepartment of Life Sciences and Engineering, University of Applied Sciences Bingen, Bingen am Rhein, Germany PubMed articlesGoogle scholar articles
  • Michael Boutros Signalling and Functional Genomics, German Cancer Research Centre, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Adelheid Cerwenka Department of Immunobiochemistry, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyEuropean Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany PubMed articlesGoogle scholar articles

Citation

Hofman T, Ng SW, Garcés-Lázaro I, et al
IFNγ mediates the resistance of tumor cells to distinct NK cell subsets
Journal for ImmunoTherapy of Cancer 2024;12:e009410. doi: 10.1136/jitc-2024-009410
Online issue publication 
July 01, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.